Clinical Trials
Initiation of Cytisine Clinical Development Program Announced By Achieve
Achieve Life Sciences, Inc. a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced initiation of...
Press Releases
Cryoport Launches – Cryoport. Certified. Cool
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), the world's leading cryogenic logistics company dedicated to the life sciences industry announced it has expanded its portfolio...
Press Releases
Perigord adds €3m in funding to drive market dominance in life science regulatory artwork software
Perigord, a Dublin based company specialised in artwork solutions for the pharma and life science industries, recorded 100% growth last year in its software...
Press Releases
Biovista expands Project Prodigy collaborations in personalized medicine
Biovista announced that it is collaborating with HPE to advance Biovista’s Project Prodigy Big Data AI healthcare platform applied in the personalized medicine vertical. ...
Drug Research
InDex Pharmaceuticals receives orphan-drug designation for pediatric ulcerative colitis in the US
InDex Pharmaceuticals Holding AB announced that the US FDA has granted orphan-drug designation for the drug candidate cobitolimod for treatment of ulcerative colitis in pediatric...
Clinical Trials
Randomization In Phase 2/3 Trial In Spinocerebellar Ataxia Completed By Biohaven
Biohaven Pharmaceutical Holding Company Ltd. announced today that it has commenced dosing of all 141 randomized patients with spinocerebellar ataxia (SCA)...
Clinical Trials
Phase III Study Of Viaskin Peanut – Allergic Of Patients One To Three Years Of Age Initiated By DBV Technologies
DBV Technologies announced that the first patient has been enrolled in EPITOPE ( EPIT in TO ddlers with PE anut Allergy), a global,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read